Oberweis Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.2M	Buy	148,601 +32,300	+28%	+$3.08M	0.48%	83
2025 Q4	$9.43M	Buy	116,301 +2,534	+2%	+$218K	0.34%	108
2025 Q3	$9.96M	Sell	113,767 -899	-0.8%	-$80.3K	0.38%	99
2025 Q2	$9.52M	Buy	114,666 +12,601	+12%	+$1.05M	0.41%	86
2025 Q1	$8.56M	Sell	102,065 -240	-0.2%	-$22.3K	0.43%	84
2024 Q4	$9.43M	Buy	102,305 +1,601	+2%	+$154K	0.44%	86
2024 Q3	$9.35M	Buy	100,704 +1	+0%	+$87	0.48%	82
2024 Q2	$8.29M	Buy	100,703 +20,702	+26%	+$1.52M	0.51%	76
2024 Q1	$5.31M	Buy	80,001 +14,701	+23%	+$907K	0.38%	103
2023 Q4	$3.71M	Buy	65,300 +8,300	+15%	+$435K	0.35%	114
2023 Q3	$3.11M	Buy	57,000 +25,400	+80%	+$1.51M	0.33%	119
2023 Q2	$2.13M	Buy	31,600 +2,900	+10%	+$177K	0.26%	127
2023 Q1	$1.48M	Buy	28,700 +7,100	+33%	+$345K	0.23%	137
2022 Q4	$994K	Buy	21,600 +7,300	+51%	+$342K	0.21%	133
2022 Q3	$725K	Buy	+14,300	New	+$715K	0.17%	134